Radiosensitizers in cervical cancer. Cisplatin and beyond

Radiation Oncology

Volumn 1, Issue 1, 2006, Pages

  Candelaria, Myrna ^a   Garcia Arias, Alicia ^a   Cetina, Lucely ^a   Dueñas Gonzalez, Alfonso ^a  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33845416730     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-1-15     Document Type: Review

References (130)

1. Parkin DM Bray F Ferlay J Pisani P Estimating the world cancer burden: Globocan 2000 Int J Cancer 2001 94 153-156 10.1002/ijc.1440 11668491
2. Richart RM Barron BA A follow-up study of patients with cervical displasia Am J Obstet Gynecol 1969 105 386-371 5810787
3. Dueñas-Gonzalez A Cetina L Mariscal I de la Garza J Modern management of locally advanced cervical carcinoma Cancer Treat Rev 2003 29 389-399 10.1016/S0305-7372(03)00068-9 12972357
4. Plante M Renaud MC Hoskins IA Roy M Vaginal radical trachelectomy: A valuable fertility-preserving option in the management of early-stage cervical cancer. A series of 50 pregnancies and review of the literature Gynecol Oncol 2005 98 3-10 10.1016/j.ygyno.2005.04.014 15936061
5. Sedlis A Bundy BN Rotman MZ Lentz SS Muderspach LI Zaino RJ A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study Gynecol Oncol 1999 73 177-183 10.1006/gyno.1999.5387 10329031
6. Peters WA 3rd Liu PY Barrett R Stock RJ Monk BJ Berek JS Souhami L Grigsby P Gordon W Jr Alberts DS Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J Clin Oncol 2000 18 1606-1613 10764420
7. Annual Report on the Results of Treatment in Gynaecological Cancer J Epidemiol Statist 1998 3 5-34
8. Brunschwig A Daniel W Evaluation of pelvic exenteration for advanced cancer of the cervix Surg Gynecol Obstet 1956 103 337-341 13360640
9. National Institutes of Health Consensus Development Conference statement on cervical cancer Gynecol Oncol 1997 66 351-361 10.1006/gyno.1997.4849 9312522
10. Whitney CW Sause W Bundy BN Malfetano JH Hannigan EV Fowler WC Jr Clarke-Pearson DL Liao SY A randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes. A Gynecologic Oncology Group and Southwest Oncology Group Study J Clin Oncol 1999 17 1339-1348 10334517
11. Morris M Eifel PJ Lu J Grigsby PW Levenback C Stevens RE Rotman M Gerhenson DM Mutch DG Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer New Engl J Med 1999 340 1137-1143 10.1056/NEJM199904153401501 10202164
12. Keys HM Bundy BN Stehman FB Muderspach LI Chafe WE Suggs CL Walker JL Gersell D A comparison of weekly cisplatin during radiation therapy versus irradiation alone each followed by adjuvant hysterectomy in bulky stage IB cervical carcinoma: A randomized trial of the Gynecology Oncology Group New Engl J Med 1999 340 1154-1161 10.1056/ NEJM199904153401503 10202166
13. Rose PG Bundy BN Watkins EB Thigpen JT Deppe G Maiman MA Clarke-Pearson DL Insalacos S Concurrent cisplatin-based chemoradiation improves progression-free survival in advanced cervical cancer: Results of a randomized Gynecologic Oncology Group study New Engl J Med 1999 340 1144-1153 10.1056/NEJM199904153401502 10202165
14. Green JA Kirwan JM Tierney JF Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: A systematic review and meta-analysis Lancet 2001 358 781-786 10.1016/ S0140-6736(01)05965-7 11564482
15. Green J Kirwan J Tierney J Vale C Symonds P Fresco L Williams C Collingwood M Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix Cochrane Database Syst Rev 2005 CD002225 16034873
16. Symonds RP Collingwood M Kirwan J Humber CE Tierney JF Green JA Williams C Concomitant hydroxyurea plus radiotherapy versus radiotherapy for carcinoma of the uterine cervix: A systematic review Cancer Treat Rev 2004 30 405-414 10.1016/j.ctrv.2003.12.002 15245773
17. Hreshchyshyn MM Aron BS Boronow RC Franklin EW 3rd Shingleton HM Blessing JA Hydroxyurea or placebo combined with radiation to treat stages IIIB and IV cervical cancer confined to the pelvis Int J Radiat Oncol Biol Phys 1979 5 317-322 110744
18. Stehman FB Bundy BN Thomas G Keys HM d'Ablaing G 3rd Fowler WC Jr Mortel R Creasman WT Hydroxyurea versus misonidazole with radiation in cervical carcinoma: Long-term follow-up of a Gynecologic Oncology Group trial J Clin Oncol 1993 11 1523-1528 8336190
19. Leibel S Bauer M Wasserman T Marcial V Rotman M Hornback N Cooper J Gillespie B Pakuris E Conner N Radiotherapy with or without misonidazole for patients with stage IIIB or stage IVA squamous cell carcinoma of the uterine cervix: Preliminary report of a Radiation Therapy Oncology Group randomized trial Int J Radiat Oncol Biol Phys 1987 13 541-549 3104249
20. Chan P Milosevic M Fyles A Carson J Pintilie M Rauth M Thomas G A phase III randomized study of misonidazole plus radiation vs. radiation alone for cervix cancer Radiother Oncol 2004 70 295-299 10.1016/ j.radonc.2003.11.018 15064016
21. Macdonald J Smalley S Benedetti J Hundahl SA Estes NC Stemmermann GN Haller DG Ajani JA Gunderson LL Jessup JM Martenson JA Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction New Engl J Med 2001 345 725-730 10.1056/NEJMoa010187 11547741
22. Thomas G Dembo A Ackerman I Franssen E Balogh J Fyles A Levin W A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluorouracil in locally advanced cervical cancer Gynecol Oncol 1998 69 137-145 10.1006/gyno.1998.4990 9600821
23. O'Connell MJ Martenson JA Wieland HS Krook JE Macdonald JS Haller DG Mayer RJ Gunderson LL Rich TA Improving adjuvant therapy for rectal cancer by combining protracted infusion fluorouracil with radiation therapy after curative surgery New Engl J Med 1994 331 502-507 10.1056/ NEJM199408253310803 8041415
24. Lanciano R Calkins A Bundy BN Parham G Lucci JA 3rd Moore DH Monk BJ O'Connor DM Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: A gynecologic oncology group study J Clin Oncol 2005 23 8289-8295 10.1200/JCO.2004.00.0497 16230678
25. Abu-Rustum NR Lee S Correa A Massad LS Compliance with and acute hematologic toxic effects of chemoradiation in indigent women with cervical cancer Gynecol Oncol 2001 81 88-91 10.1006/gyno.2000.6109 11277656
26. Serkies K Jassem J Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: A report on patient compliance and acute toxicity Int J Radiat Oncol Biol Phys 2004 60 814-821 10.1016/ j.ijrobp.2004.04.042 15465198
27. Cetina L Rivera L Hinojosa J Poitevin A Uribe J López-Graniel C Cantú D Candelaria M de la Garza J Dueñas-González A Routine management of locally advanced cervical cancer with concurrent radiation and cisplatin. Five-year results BMC Women's Health 2006 6 3 1420274 16464243 10.1186/1472-6874-6-3
28. Schaake-Koning C van den Bogaert W Dalesio O Festen J Hoogenhout J van Houtte P Kirkpatrick A Koolen M Maat B Nijs A Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer New Engl J Med 1992 326 524-530 1310160
29. Mitsuhashi A Uno T Tanaka N Suzuka K Tate S Yamazawa K Matsui H Yamamoto S Ito H Sekiya S Phase I study of daily cisplatin and concurrent radiotherapy in patients with cervical carcinoma Gynecol Oncol 2005 96 194-197 10.1016/j.ygyno.2004.09.038 15589600
30. Yang LX Douple EB O'Hara JA Wang HJ Production of DNA double-strand breaks by interactions between carboplatin and radiation: A potential mechanism for radiopotentiation Radiat Res 1995 143 309-315 7652169
31. Knox RJ Friedlos F Lydall DA Roberts JJ Mechanism of cytotoxicity of anticancer platinum drugs: Evidence that cisdiamminedichloroplatinum (II) and cis-diammine-(1,1-cyclobutanedicarboxylato) platinum(II) differ only in the kinetics of their interaction with DNA Cancer Res 1986 46 1972-1979 3512077
32. Lokich J Anderson N Carboplatin versus cisplatin in solid tumors: An analysis of the literature Ann Oncol 1998 9 13-21 10.1023/ A:1008215213739 9541678
33. Douple EB Richmond RC O'Hara JA Coughlin CT Carboplatin as a potentiator of radiation therapy Cancer Treat Rev 1985 12 111-124 10.1016/ 0305-7372(85)90026-X 3910216
34. Hopkins MP Morley GW Prognostic factors in advanced stage squamous cell cancer of the cervix Cancer 1993 72 2389-2393 8402454
35. Klahr S Morrison A Buerkert J Effects of urinary tract obstruction on renal function Contrib Nephrol 1980 23 34-46 7002453
36. Duan SB Wu HW Luo JA Liu FY Assessment of renal function in the early stages of nephrotoxicity induced by iodinated contrast media Nephron 1999 83 122-125 10.1159/000045488 10516490
37. Micheletti E La Face B Bianchi E Cagna E Apostoli P Ruggeri G Verardi R Sartori E Continuous infusion of carboplatin during conventional radiotherapy treatment in advanced squamous carcinoma of the cervix uteri IIB-IIIB (UICC). A phase I/II and pharmacokinetic study Am J Clin Oncol 1997 20 613-620 10.1097/00000421-199712000-00017 9391552
38. Muderspach LI Curtin JP Roman LD Gebhardt JA Klement V Qian D Morrow CP Felix JC Formenti SC Muggia FM Carboplatin as a radiation sensitizer in locally advanced cervical cancer: A pilot study Gynecol Oncol 1997 65 336-342 10.1006/gyno.1997.4647 9159348
39. Duenas-Gonzalez A Cetina L Sanchez B Gomez E Rivera L Hinojosa J Lopez-Graniel C Gonzalez-Enciso A de la Garza J A phase I study of carboplatin concurrent with radiation in FIGO stage IIIB cervix uteri carcinoma Int J Radiat Oncol Biol Phys 2003 56 1361-1365 10.1016/ S0360-3016(03)00347-X 12873681
40. Weiss RB Christian MC New cisplatin analogues in development. A review Drugs 1993 46 360-377 7693428
41. Monk BJ Alberts DS Burger RA Fanta PT Hallum AV 3rd Hatch KD Salmon SE In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancers Gynecol Oncol 1998 71 308-312 10.1006/gyno.1998.5140 9826477
42. Kamiura S Kobayashi K Ohira H Seino H Hashimoto N Sawai K Samejima Y Saji F [Concurrent chemoradiation therapy with nedaplatin for high-risk cervical cancer - clinical investigation of adverse events] Gan To Kagaku Ryoho 2001 28 979-986 11478148
43. Cividalli A Ceciarelli F Livdi E Altavista P Cruciani G Marchetti P Danesi DT Radiosensitization by oxaliplatin in a mouse adenocarcinoma: influence of treatment schedule Int J Radiat Oncol Biol Phys 2002 52 1092-1098 10.1016/S0360-3016(01)02792-4 11958906
44. Kjellstrom J Kjellen E Johnsson A In vitro radiosensitization by oxaliplatin and 5-fluorouracil in a human colon cancer cell line Acta Oncol 2005 44 687-693 10.1080/02841860500247552 16227158
45. Turitto G Panelli G Frattolillo A Auriemma A de Luna FS Cione G De Angelis CP Muto P Iaffaioli RV Phase II study of neoadjuvant concurrent chemioradiotherapy with oxaliplatin-containing regimen in locally advanced rectal cancer Front Biosci 2006 11 1275-1279 16368513
46. Fracasso PM Blessing JA Wolf J Rocereto TF Berek JS Waggoner S Phase II evaluation of oxaliplatin in previously treated squamous cell carcinoma of the cervix: A gynecologic oncology group study Gynecol Oncol 2003 90 177-180 10.1016/S0090-8258(03)00253-1 12821360
47. Duenas-Gonzalez A Lopez-Graniel C Gonzalez A Gomez E Rivera L Mohar A Chanona G Trejo-Becerril C de la Garza J Induction chemotherapy with gemcitabine and oxaliplatin for locally advanced cervical carcinoma Am J Clin Oncol 2003 26 22-25 10.1097/00000421-200302000-00005 12576919
48. Danson S Ward TH Butler J Ranson M DT-diaphorase: A target for new anticancer drugs Cancer Treat Rev 2004 30 437-449 10.1016/ j.ctrv.2004.01.002 15245776
49. Siegel D Gibson NW Preusch PC Ross D Metabolism of mitomycin C by DT-diaphorase: Role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells Cancer Res 1990 50 7483-7489 1701346
50. Flam M John M Pajak TF Petrelli N Myerson R Doggett S Quivey J Rotman M Kerman H Coia L Murray K Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study J Clin Oncol 1996 14 2527-2539 8823332
51. Evans LS Kersh CR Constable WC Taylor PT Concomitant 5-fluorouracil, mitomycin-C, and radiotherapy for advanced gynecologic malignancies Int J Radiat Oncol Biol Phys 1988 15 901-906 3141319
52. Ludgate SM Crandon AJ Hudson CN Walker Q Langlands AO Synchronous 5-fluorouracil, mitomycin-C and radiation therapy in the treatment of locally advanced carcinoma of the cervix Int J Radiat Oncol Biol Phys 1988 15 893-899 3141318
53. Thomas G Dembo A Beale F Bean H Bush R Herman J Pringle J Rawlings G Sturgeon J Fine S Concurrent radiation, mitomycin C and 5-fluorouracil in poor prognosis carcinoma of cervix: Preliminary results of a phase I-II study Int J Radiat Oncol Biol Phys 1984 10 1785-1790 6434500
54. Lorvidhaya V Chitapanarux I Sangruchi S Lertsanguansinchai P Kongthanarat Y Tangkaratt S Visetsiri E Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: A randomized trial Int J Radiat Oncol Biol Phys 2003 55 1226-1232 10.1016/S0360-3016(02)04405-X 12654431
55. Chirstophidis N Vajda FJ Lucas I Drummer O Moon WJ Louis WJ Fluorouracil therapy in patients with carcinoma of the large bowel: A pharmacokinetic comparison of various rates and routes of administration Clin Pharmacokinet 1978 3 330-336 678346
56. Roberts KB Urdaneta N Vera R Vera A Gutierrez E Aguilar Y Ott S Medina I Sempere P Rockwell S Sartorelli AC Fischer DB Fischer JJ Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous-cell carcinoma of the cervix Int J Cancer 2000 90 206-223 10.1002/ 1097-0215(20000820)90:4<206::AID-IJC4>3.0.CO;2-O 10993961
57. Christie DR Bull CA Gebski V Langlands AO Concurrent 5-fluorouracil, mitomycin C and irradiation in locally advanced cervix cancer Radiother Oncol 1995 37 181-189 10.1016/0167-8140(95)01648-1 8746586
58. Rakovitch E Fyles AW Pintilie M Leung PM Role of mitomycin C in the development of late bowel toxicity following chemoradiation for locally advanced carcinoma of the cervix Int J Radiat Oncol Biol Phys 1997 38 979-987 10.1016/S0360-3016(97)00121-1 9276362
59. Nigro ND Vaitkevicius VK Considine B Jr Combined therapy for cancer of the anal canal: A preliminary report Dis Colon Rectum 1974 17 354-356 4830803
60. Hung A Crane C Delclos M Ballo M Ajani J Lin E Feig B Skibber J Janjan N Cisplatin-based combined modality therapy for anal carcinoma: A wider therapeutic index Cancer 2003 97 1195-1202 10.1002/cncr.11161 12599225
61. Wong LC Choy DT Ngan HY Sham JS Ma HH 4-epidoxorubicin in recurrent cervical cancer Cancer 1989 63 1279-1282 2920356
62. Calero F Rodriguez-Escudero F Jimeno J Mendana J Iglesias J Murillo F Ugalde F Armas A Rementeria A Asins J Single agent epirubicin in squamous cell cervical cancer. A phase II trial Acta Oncol 1991 30 325-327 2036241
63. Jagetia GC Nayak V Effect of doxorubicin on cell survival and micronuclei formation in HeLa cells exposed to different doses of gamma-radiation Strahlenther Onkol 2000 176 422-428 10.1007/PL00002351 11050916
64. Ban J Bistrovic M Maricic Z Kolaric K Combined treatment of 4′-epi-doxorubicin and radiation on hamster lung cells Tumori 1986 72 339-344 3532468
65. Wong LC Ngan HY Cheung AN Cheng DK Ng TY Choy DT Chemoradiation and adjuvant chemotherapy in cervical cancer J Clin Oncol 1999 17 2055-2060 10561258
66. Garcia-Carbonero R Supko JG Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins Clin Cancer Res 2002 8 641-661 11895891
67. Chen AY Choy H Rothenberg ML DNA topoisomerase I-targeting drugs as radiation sensitizers Oncology 1999 13 39-46 10550825
68. Perego P Capranico G Supino R Zunino F Topoisomerase I gene expression and cell sensitivity to camptothecin in human cell lines of different tumor types Anticancer Drugs 1994 5 645-649 7888702
69. Chen BM Chen JY Kao M Lin JB Yu MH Roffler SR Elevated topoisomerase I activity in cervical cancer as a target for chemoradiation therapy Gynecol Oncol 2000 79 272-280 10.1006/gyno.2000.5947 11063656
70. Dunton CJ King SA Neufeld J Tolosa J Perez G Avila A Underhill K Phase I study of topotecan and radiation therapy in advanced cervical cancer Gynecol Oncol 2002 85 185-187 10.1006/gyno.2002.6609 11925142
71. Bell MC Davidson SA Mathis JM Ampil F Topotecan concomitant with primary brachytherapy radiation in patients with cervical carcinoma: A phase I trial Gynecol Oncol 2001 80 128-131 10.1006/gyno.2000.6051 11161849
72. Lhomme C Fumoleau P Fargeot P Krakowski Y Dieras V Chauvergne J Vennin P Rebattu P Roche H Misset JL Lentz MA Van Glabbeke M Matthieu-Boue A Mignard D Chevallier B Results of a European Organization for Research and Treatment of Cancer/Early Clinical Studies Group phase II trial of first-line irinotecan in patients with advanced or recurrent squamous cell carcinoma of the cervix J Clin Oncol 1999 17 3136-3142 10506610
73. Muggia FM Blessing JA McGehee R Monk BJ Cisplatin and irinotecan in squamous cell carcinoma of the cervix: A phase II study of the Gynecologic Oncology Group Gynecol Oncol 2004 94 483-487 10.1016/ j.ygyno.2004.05.018 15297192
74. Tanaka T Yukawa K Umesaki N Combination effects of irradiation and irinotecan on cervical squamous cell carcinoma cells in vitro Oncol Rep 2005 14 1365-1369 16211310
75. Edelstein MP Wolfe LA 3rd Duch DS Potentiation of radiation therapy by vinorelbine (Navelbine) in non-small cell lung cancer Semin Oncol 1996 23 41-47 8610236
76. Fukuoka K Arioka H Iwamoto Y Fukumoto H Kurokawa H Ishida T Tomonari A Suzuki T Usuda J Kanzawa F Saijo N Nishio K Mechanism of the radiosensitization induced by vinorelbine in human non-small cell lung cancer cells Lung Cancer 2001 34 451-460 10.1016/S0169-5002(01)00265-3 11714543
77. Fukuoka K Arioka H Iwamoto Y Fukumoto H Kurokawa H Ishida T Tomonari A Suzuki T Usuda J Kanzawa F Kimura H Saijo N Nishio K Mechanism of vinorelbine-induced radiosensitization of human small cell lung cancer cells Cancer Chemother Pharmacol 2002 49 385-390 10.1007/ s00280-002-0430-x 11976832
78. Mundt AJ Rotmensch J Waggoner SE Yamada D Langhauser C Fleming GF Phase I trial of concomitant vinorelbine, paclitaxel, and pelvic irradiation in cervical carcinoma and other advanced pelvic malignancies Gynecol Oncol 2001 82 333-337 10.1006/gyno.2001.6101 11531289
79. Tishler RB Schiff PB Geard CR Hall EJ Taxol: A novel radiation sensitizer Int J Radiat Oncol Biol Phys 1992 22 613-617 1346533
80. Liebmann J Cook JA Fisher J Teague D Mitchell JB In vitro studies of Taxol as a radiation sensitizer in human tumor cells J Natl Cancer Inst 1994 86 441-446 7907149
81. Rave-Frank M Meden H Jaschke A Tanzer A Boghun O Fietkau R The effect of paclitaxel on the radiosensitivity of gynecological tumor cells Strahlenther Onkol 1997 173 281-286 9176559
82. Rodriguez M Sevin BU Perras J Nguyen HN Pham C Steren AJ Koechli OR Averette HE Paclitaxel: A radiation sensitizer of human cervical cancer cells Gynecol Oncol 1995 57 165-169 10.1006/gyno.1995.1119 7729728
83. Erlich E McCall AR Potkul RK Walter S Vaughan A Paclitaxel is only a weak radiosensitizer of human cervical carcinoma cell lines Gynecol Oncol 1996 60 251-254 10.1006/gyno.1996.0034 8631547
84. Hennequin C Giocanti N Favaudon V Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (Taxotere) in HeLa and SQ20B cells Cancer Res 1996 56 1842-1850 8620502
85. Cerrotta A Gardan G Cavina R Raspagliesi F Stefanon B Garassino I Musumeci R Tana S De Palo G Concurrent radiotherapy and weekly paclitaxel for locally advanced or recurrent squamous cell carcinoma of the uterine cervix. A pilot study with intensification of dose Eur J Gynaecol Oncol 2002 23 115-119 12013105
86. Chen MD Paley PJ Potish RA Twiggs LB Phase I trial of taxol as a radiation sensitizer with cisplatin in advanced cervical cancer Gynecol Oncol 1997 67 131-136 10.1006/gyno.1997.4851 9367695
87. Pignata S Frezza P Tramontana S Perrone F Tambaro R Casella G Ferrari E Iodice F De Vivo R Ricchi P Tramontana F Silvestro G Phase I study with weekly cisplatin-paclitaxel and concurrent radiotherapy in patients with carcinoma of the cervix uteri Ann Oncol 2000 11 455-459 10.1023/ A:1008379922120 10847466
88. Rao GG Rogers P Drake RD Nguyen P Coleman RL Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer Gynecol Oncol 2005 96 168-172 10.1016/ j.ygyno.2004.09.009 15589596
89. Pauwels B Korst AE Lardon F Vermorken JB Combined modality therapy of gemcitabine and radiation Oncologist 2005 10 34-51 10.1634/ theoncologist.10-1-34 15632251
90. Lawrence TS Eisbruch A Shewach DS Gemcitabine-mediated radiosensitization Semin Oncol 1997 24 24-28
91. Hernández P Olivera P Dueñas-Gonzalez A Perez-Pastenes MA Zarate A Maldonado V Melendez-Zajgla J Gemcitabine activity in cervical cancer cell lines Cancer Chemother Pharmacol 2001 48 488-492 10.1007/ s002800100370 11800030
92. Mose S Karapetian M Juling-Pohlit L [The intensification of the radiotherapeutic effect on HeLa cells by gemcitabine] Strahlenther Onkol 1999 175 78-83 10065143
93. Dueñas-Gonzalez A Gonzalez EA Lopez-Graniel C A phase II study of gemcitabine and cisplatin combination as induction chemotherapy for untreated locally advanced cervical carcinoma Ann Oncol 2001 12 541-547 10.1023/A:1011117617514 11398890
94. Dueñas-Gonzalez A Lopez-Graniel C Gonzalez AE Induction chemotherapy with gemcitabine and oxaliplatin for locally advanced cervical carcinoma Am J Clin Oncol 2003 26 22-25 10.1097/ 00000421-200302000-00005 12576919
95. McCormack M Thomas H A phase Ib study of gemcitabine (GEM) and concurrent radiotherapy (RT) in carcinoma of the cervix Ann Oncol 2000 11 88-89
96. Pattaranutaporn P Thirapakawong C Chansilpa Y Thersakvivhya S Ieumwananontachai N Thephamongkhol K Phase II study of concurrent gemcitabine and radiotherapy in locally advanced stage IIIB cervical carcinoma Gynecol Oncol 2001 81 404-407 10.1006/gyno.2001.6197 11371129
97. Boualga K A phase II study of gemcitabine (G) and concomitant radiotherapy (R) in locally advanced carcinoma of the cervix (LACC) Int J Cancer 2002 13 378
98. Cetina L Rivera L Candelaria M de la Garza J Duenas-Gonzalez A Chemoradiation with gemcitabine for cervical cancer in patients with renal failure Anticancer Drugs 2004 15 761-766 10.1097/ 00001813-200409000-00004 15494637
99. Alvarez AM Mickiewicz E Roth B Bonomi M Brosio C Porcella H Rodger J Menendez P Giglio R de Dios D Cinat G Lizos S Feasibility of accelerated radiotherapy (Rt) concurrent with low dose biweekly gemcitabine (G) and cisplatin (C) in locally advanced cervical carcinoma (LACC) [abstract] Procc ASCO 2001 20 100a
100. Alvarez AM Mickiewicz E Rodger J Bonomi M Brosio CA Menendez Gianni S Giglio R de Dios D Cinat G Lizos S Pogany C Carnaval H Porcella H Roth B Radiotherapy (RT) with low dose biweekly gemcitabine (LDBG) and cisplatin in locally advanced cervical carcinoma (LACC): Stages IIA-IVA [abstract] Procc ASCO 2002 21 224a
101. Zarba JJ Jaremtchuk AV Gonzalez Jazey P Keropian M Castagnino R Mina C Arroyo G A phase I-II study of weekly cisplatin and gemcitabine with concurrent radiotherapy in locally advanced cervical carcinoma Ann Oncol 2003 14 1285-1290 10.1093/annonc/mdg345 12881394
102. Candelaria M Chanona-Vilchis J Cetina L Flores-Estrada D Carlos López-Graniel C González-Enciso A Cantú D Poitevin A Rivera L Hinojosa J de la Garza J Dueñas-Gonzalez A Prognostic significance of pathological response after neoadjuvant chemotherapy or chemoradiation for locally advanced cervical carcinoma Int Semin Surg Oncol 2006 3 3 1386679 16457727 10.1186/1477-7800-3-3
103. Duenas-Gonzalez A Cetina-Perez L Lopez-Graniel C Gonzalez-Enciso A Gomez-Gonzalez E Rivera-Rubi L Montalvo-Esquivel G Munoz-Gonzalez D Robles-Flores J Vazquez-Govea E de La Garza J Mohar A Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer: A randomized Phase II study Int J Radiat Oncol Biol Phys 2005 61 817-823 10.1016/ j.ijrobp.2004.07.676 15708261
104. Swisher EM Swensen RE Greer B Tamimi H Goff BA Garcia R Koh WJ Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of cervical cancer: A phase I trial of the Puget Sound Oncology Consortium Gynecol Oncol 2005, Dec 7
105. Umanzor J Aguiluz M Pineda C Andrade S Erazo M Flores C Santillana S Concurrent cisplatin/gemcitabine chemotherapy along with radiotherapy in locally advanced cervical carcinoma: A phase II trial Gynecol Oncol 2006 100 70-75 10.1016/j.ygyno.2005.07.132 16288803
106. Miwa M Ura M Nishida M Sawada N Ishikawa T Mori K Simma N Umeda I Ishitsuka H Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue Eur J Cancer 1998 34 1274-1281 10.1016/S0959-8049(98)00058-6 9849491
107. Ishikawa T Sekiguchi F Fukase Y Sawada N Ishitsuka H Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts Cancer Res 1998 58 685-690 9485021
108. Ueda M Terai Y Kumaga K Ueki K Kanemura M Ueki M Correlation between thymidine phosphorylase expression and invasion phenotype in cervical carcinoma cells Int J Cancer 2001 91 778-782 10.1002/ 1097-0215(200002)9999:9999<::AID-IJC1133>3.0.CO;2-S 11275979
109. Sawada N Ishikawa T Sekiguchi F X ray irradiation induces thymidine phosphorylase and enhances the efficacy of Capecitabine (Xeloda) in human cancer Xenografts Clin Cancer Res 1999 5 2948-2953 10537364
110. Torrecillas L Ballesteros G Cervantes P Capecitabine chemoradiation for stage IIb-IIIb cervical cancer. Preliminary Phase I Results of the Mexican Oncology Group [abstract] Procc ECCO 2003 12 163
111. Souglakos J Androulakis N Mavroudis D Kourousis C Kakolyris S Vardakis N Kalbakis K Pallis A Ardavanis A Varveris C Georgoulias V Multicenter dose-finding study of concurrent capecitabine and radiotherapy as adjuvant treatment for operable rectal cancer Int J Radiat Oncol Biol Phys 2003 56 1284 1287 10.1016/S0360-3016(03)00275-X 12873672
112. Ngan SY Michael M Mackay J McKendrick J Leong T Lim Joon D Zalcberg JR A phase I trial of preoperative radiotherapy and capecitabine for locally advanced, potentially resectable rectal cancer Br J Cancer 2004 91 1019-1024 15305186
113. Van Cutsem E Hoff PM Harper P Bukowski RM Cunningham D Dufour P Graeven U Lokich J Madajewicz S Maroun JA Marshall JL Mitchell EP Perez-Manga G Rougier P Schmiegel W Schoelmerich J Sobrero A Schilsky RL Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: Integrated efficacy data and novel analyses from two large, randomised, phase III trials Br J Cancer 2004 90 1190-1197 10.1038/sj.bjc.6601676 15026800
114. Stokes Z Symonds P Habeshaw T Reed N Curto J Joynson C Chan S Phase one dose finding study of capecitabine (Xeloda), radiotherapy and cisplatin in the treatment of locally advanced squamous cervical cancer Gynecol Oncol 2005 97 790-795 10.1016/j.ygyno.2005.03.020 15894361
115. Hoffmann W Blase MA Santo-Hoeltje L Herskind C Bamberg M Rodemann HP Radiation sensitivity of human squamous cell carcinoma cells in vitro is modulated by all-trans and 13-cis-retinoic acid in combination with interferon-alpha Int J Radiat Oncol Biol Phys 1999 45 991-998 10.1016/ S0360-3016(99)00298-9 10571207
116. Moore DM Kalvakolanu DV Lippman SM Kavanagh JJ Hong WK Borden EC Paredes-Espinoza M Krakoff IH Retinoic acid and interferon in human cancer: Mechanistic and clinical studies Semin Hematol 1994 31 31-37 7831583
117. Lippman SM Kavanagh JJ Paredes-Espinoza M Delgadillo-Madrueno F Paredes-Casillas P Hong WK Holdener E Krakoff IH 13-cis-retinoic acid plus interferon alpha-2a: Highly active systemic therapy for squamous cell carcinoma of the cervix J Natl Cancer Inst 1992 84 241-245 1734085
118. Weiss GR Liu PY Alberts DS Peng YM Fisher E Xu MJ Scudder SA Baker LH Jr Moore DF Lippman SM 13-cis-retinoic acid or all-trans-retinoic acid plus interferon-alpha in recurrent cervical cancer: A Southwest Oncology Group phase II randomized trial Gynecol Oncol 1998 71 386-390 10.1006/ gyno.1998.5204 9887236
119. Hallum AV 3rd Alberts DS Lippman SM Inclan L Shamdas GJ Childers JM Surwit EA Modiano M Hatch KD Phase II study of 13-cis-retinoic acid plus interferon-alpha 2a in heavily pretreated squamous carcinoma of the cervix Gynecol Oncol 1995 56 382-386 10.1006/gyno.1995.1067 7705672
120. Park TK Lee JP Kim SN Choi SM Kudelka AP Kavanagh JJ Interferon-alpha 2a, 13-cis-retinoic acid and radiotherapy for locally advanced carcinoma of the cervix: A pilot study Eur J Gynaecol Oncol 1998 19 35-38 9476056
121. Yazigi R Aliste G Torres R Ciudad AM Cuevas M Garrido J Prado S Sola A Castillo R Cerda B Cumsille MA Gonzalez M Navarro C Reyes JM Phase III randomized pilot study comparing interferon alpha-2b in combination with radiation therapy versus radiation therapy alone in patients with stage III-B carcinoma of the cervix Int J Gynecol Cancer 2003 13 164-169 10.1046/j.1525-1438.2003.13031.x 12657118
122. Dietzel F Basic principles in hyperthermic tumor therapy. Recent Results Cancer Res 1983 86 177-190
123. Griffin RJ Ogawa A Williams BW Song CW Hyperthermic enhancement of tumor radiosensitization strategies Immunol Invest 2005 34 343-359 10.1081/ IMM-200066270 16136785
124. Harima Y Nagata K Harima K Ostapenko VV Tanaka Y Sawada S A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma Int J Hyperthermia 2001 17 97-105 10.1080/ 02656730010001333 11252361
125. Vasanthan A Mitsumori M Park JH Zhi-Fan Z Yu-Bin Z Oliynychenko P Tatsuzaki H Tanaka Y Hiraoka M Regional hyperthermia combined with radiotherapy for uterine cervical cancers: A multi-institutional prospective randomized trial of the international atomic energy agency Int J Radiat Oncol Biol Phys 2005 61 145-153 10.1016/ j.ijrobp.2004.04.057 15629605
126. Ma BB Bristow RG Kim J Siu LL Combined-modality treatment of solid tumors using radiotherapy and molecular targeted agents J Clin Oncol 2003 21 2760-2776 10.1200/JCO.2003.10.044 12860956
127. Chen Y Okunieff P Radiation and third-generation chemotherapy Hematol Oncol Clin North Am 2004 18 55-80 10.1016/S0889-8588(03)00145-X 15005281
128. Gupta S Ahmed MM A global perspective of radiation-induced signal transduction pathways in cancer therapeutics Indian J Exp Biol 2004 42 1153-1176 15623227
129. Duenas-Gonzalez A Lizano M Candelaria M Cetina L Arce C Cervera E Epigenetics of cervical cancer. An overview and therapeutic perspectives Mol Cancer 2005 4 38 1291396 16248899 10.1186/1476-4598-4-38
130. Arce C Segura-Pacheco B Perez-Cardenas E Taja-Chayeb L Candelaria M Duenas-Gonzalez A Hydralazine target: From blood vessels to the epigenome J Transl Med 2006 4 10 1413557 16507100 10.1186/1479-5876-4-10